• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number C24101E
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Code Available (3191)
Event Date 03/27/2017
Event Type  Injury  
Manufacturer Narrative
No product will be returned per customer.The customer¿s complaint could not be confirmed because the product was not sequestered and will not be returned for failure investigation.The root cause of this failure was not identified.
 
Event Description
Received a copy of the customer's medwatch report from the fda which states, "called emergently to bedside of patient with acute change in perfusion/hemodynamic status.Head ct performed with findings of cortical venous air consistent with air embolism.Patient is now stable but remains critically ill.Later evaluation of representative product used for patient demonstrates that filter on the tubing will empty on inlet side then allowing air to enter into tubing by "back priming" the filter with fluid distal to filter.Patient likely received a minimum of 3ml of air.It is unknown exactly how long the patient received air.Iv access was a picc in a scalp vein.Location confirmed on x-ray and estimated catheter tip location svc/ra junction.(please note this patient has a mixing cardiac lesion so flow will shunt from right to left).Iv pump did not alert with air in line as filter was below pump.Iv pump is carefusion alaris pump and was not pulled out of service since filter bypasses pump." the customer reported that on (b)(6) 2017 at 1833 tpn 20.25ml/hr was initiated; lipids were also infusing at an unspecified rate.The filter was primed lying horizontally on a sterile drape.The level of the device was above the patient.The customer reported that it was unknown if there was any disability or lasting effects.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS® PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer (Section G)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer Contact
stephen bilello
10020 pacific mesa blvd
san diego, CA 92121-4386
8586172000
MDR Report Key6549036
MDR Text Key74550593
Report Number9616066-2017-00727
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Risk Manager
Type of Report Initial
Report Date 04/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/05/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberC24101E
Device Catalogue NumberC24101E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received04/17/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
(B)(4),PRI TUBING,PICC,THERAPY DATE (B)(6) 2017
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age6 DA
-
-